In the early stages of tumorigenesis, TGF-β can act as a tumor suppressor; however, during cancer progression, TGF-β can activate cell growth, cancer progression, and dissemination through the promotion of epithelial-to-mesenchymal transition (EMT), angiogenesis, and escape from immune system [34]. Here, TGFB1 is linked to cancer.